Latest Breaking News On - ஹெபடைடிஸ் மருந்து - Page 1 : comparemela.com
URL copied
Zydus Cadila seeks DCGI nod for use of hepatitis drug for COVID-19 treatment
Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General of India (DCGI) for the additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating COVID-19. Phase-III clinical trials with Pegylated Interferon Alpha 2b, which the company sells under the brand name PegiHep has shown promising results in treating COVID-19, Zydus Cadila said in a statement.
The interim results indicate that the drug when administered early on, could help patients recover faster and avoid much of the complications seen in the advanced stages of the disease, it added.
Mexico
United-states
India
Zydus-cadila
Sharvil-patel
Zydus-group
Drug-administration
Image-source
Drugs-controller-general
Pegylated-interferon
Pegylated-interferon-alpha
Indian-innovation